Aflibercept demonstrates long-term efficacy for polypoidal choroidal vasculopathy

• Posted on: May 2 2019
• By: Saratoga Opthalmology
• Leave a response

This prospective phase 3b/4 study assessed the long-term efficacy and safety of intravitreal aflibercept with or without rescue photodynamic therapy for polypoidal choroidal vasculopathy.
Source: AAO

Posted in: Uncategorized